OPCH · NASDAQ
Option Care Health, Inc.
$31.83 -0.04 (-0.11%)
Company overview
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies and home infusion services to treat heart failures. It also offers home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases. Option Care Health provides immunoglobulin infusion therapies for the treatment of immune deficiencies and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NASDAQ
- Market cap
- $4.8B
- Employees
- 8,000
- Headquarters
- Bannockburn, IL
- Website
- optioncarehealth.com
- CEO
- Luke Whitworth
- Listed
- August 15, 1996
- P/E
- 24.67
- Dividend yield
- 0.00%
Company financials
- Revenue
- $5.7B
- Gross profit
- $1B
- Operating income
- $336M
- EBITDA
- $406M
- Net income
- $206M
- EPS
- $1.29
- Total assets
- $3.4B
- Total debt
- $0.00
- Gross margin
- 18.00%
- Net margin
- 3.64%
- Earnings yield
- 4.05%
No geographic segmentation.
Showing FY 2025
OPCH
1D
NASDAQ
O31.80H31.90L31.77C31.82-0.04 (-0.11%)Vol1.26M